Patent ID: 6492407
Filing Date: 2002-12-10
Classification: A61P,C07D

Abstract:
A pharmaceutical composition comprising a compound selected from the group consisting of:(a) 2-(2-methylphenyl)-5-phenyl-3H-1,2,4-triazol-3-one; (b) 2-(3-methoxyphenyl)-4-methyl-5-phenyl-3H-1,2,4-triazol-3-one; (c) 2-(2-bromophenyl)-4-methyl-5-phenyl-3H-1,2,4-triazol-3-one; (d) 5-(4-methoxyphenyl)-4-methyl-2-phenyl-3H-1,2,4-triazol-3-one; (e) 5-(2-methoxyphenyl)-4-methyl-2-phenyl-3H-1,2,4-triazol-3-one; (f) 4-(2-N,N-dimethylaminoethyl)-2-(2-methylphenyl)-5-phenyl-3H-1,2,4-triazol-3-one; (g) 2-(2-methoxyphenyl)-5-phenyl-3H-1,2,4-triazol-3-one; (h) 2-(2-chlorophenyl)-5-phenyl-3H-1,2,4-triazol-3-one; (i) 2-(3-chlorophenyl)-4-(2-N,N-dimethylaminoethyl)-5-phenyl-3H-1,2,4-triazol-3-one; (j) 2-(2-fluorophenyl)-5-phenyl-3H-1,2,4-triazol-3-one; (k) 2-(3-fluorophenyl)-4-methyl-5-phenyl-3H-1,2,4-triazol-3-one; (l) 2-(2-fluorophenyl)-4-methyl-5-phenyl-3H-1,2,4-triazol-3-one; (m) 2-(3-methylphenyl)-5-phenyl-3H-1,2,4-triazol-3-one; (n) 2-(2-ethylphenyl)-5-phenyl-3H-1,2,4-triazol-3-one; (o) 2-(3-fluorophenyl)-4-(2-N,N-dimethylaminoethyl)-5-phenyl-3H-1,2,4-triazol-3-one; (p) 4-methyl-2-(3-methylphenyl)-5-phenyl-3H-1,2,4-triazol-3-one; (q) 4-(2-N,N-dimethylaminoethyl)-2-(3-methylphenyl)-5-phenyl-3H-1,2,4-triazol-3-one; (r) 2-(2-chlorophenyl)-4-methyl-5-phenyl-3H-1,2,4-triazol-3-one; and (s) 2-(2-bromophenyl)-5-phenyl-3H-1,2,4-triazol-3-one, or pharmaceutically acceptable salts thereof.